ChemicalBook >> CAS DataBase List >>GSK 2033

GSK 2033

GSK 2033 structure

CAS No.: 1221277-90-2

Chemical Name:: GSK 2033

Synonyms: GSK 2033;LXR antagonist 2033;GSK2033 >=98% (HPLC);Liver X receptor,Inhibitor,GSK 2033,inhibit,LXR,GSK2033,GSK-2033;2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide;Benzenesulfonamide, 2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]-

CBNumber:: CB93146298

Molecular Formula:: C29H28F3NO5S2

Molecular Weight:: 591.66

MDL Number:: MFCD28396416

MOL File:: 1221277-90-2.mol

MSDS File:: SDS

Last updated:2023-06-30 15:45:59

Request For Quotation

GSK 2033 Properties

storage temp.	2-8°C
solubility	DMF:5.0(Max Conc. mg/mL);8.45(Max Conc. mM) DMSO:17.46(Max Conc. mg/mL);29.51(Max Conc. mM)
form	powder
color	white to beige

SAFETY

Risk and Safety Statements

Symbol(GHS)	GHS07
Signal word	Warning
Hazard statements	H302-H315-H319-H335
Precautionary statements	P261-P305+P351+P338

GSK 2033 price More Price(16)

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
Sigma-Aldrich	SML1617	GSK2033 ≥98% (HPLC)	1221277-90-2	5MG	$159	2023-06-20	Buy
Sigma-Aldrich	SML1617	GSK2033 ≥98% (HPLC)	1221277-90-2	25MG	$639	2023-06-20	Buy
Cayman Chemical	25443	GSK2033 ≥98%	1221277-90-2	1mg	$32	2024-03-01	Buy
Cayman Chemical	25443	GSK2033 ≥98%	1221277-90-2	5mg	$139	2024-03-01	Buy
Cayman Chemical	25443	GSK2033 ≥98%	1221277-90-2	10mg	$230	2024-03-01	Buy

Product number	Packaging	Price	Buy
SML1617	5MG	$159	Buy
SML1617	25MG	$639	Buy
25443	1mg	$32	Buy
25443	5mg	$139	Buy
25443	10mg	$230	Buy

GSK 2033 Chemical Properties,Uses,Production

Uses

GSK 2033 is a potent LXR antagonist.

Biochem/physiol Actions

GSK2033 is an antagonist of the nuclear receptor liver-X-receptor (LXR) with pIC50 values of 7.0 for LXRα and 7.4 for LXRβ. Treatment of murine CD41 T cells with GSK2033 enhanced cellular proliferation and Th1/Th2/Th17 differentiation. In another study, the conjugated linoleic acid (CLA)-induced expression of efflux protein ATP-binding-cassette transporter A1 (ABCA1) was completely abolished by preincubation with GSK2033, showing that CLA mediated regulation of ABCA-1 expression is LXR dependent.

storage

Store at +4°C

GSK 2033 Preparation Products And Raw materials

Raw materials

Preparation Products

GSK 2033 Suppliers

Global( 46)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
ATK CHEMICAL COMPANY LIMITED	+undefined-21-51877795	ivan@atkchemical.com	China	32480	60
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
Chemia Biotechnology（Shanghai） Co., Ltd	+8613816753574	info@chemia-pharm.com	CHINA	311	58
InvivoChem	+1-708-310-1919 +1-13798911105	sales@invivochem.cn	United States	6393	58
Nantong HI-FUTURE Biology Co., Ltd.	+undefined18051384581	sales@chemhifuture.com	China	3136	58
Jilin Chinese Academy of Sciences-yanshen Technology	+undefined18143011203	info@chemextension.com	China	42057	58
Aladdin Scientific	+1-833-552-7181	sales@aladdinsci.com	United States	57511	58
ShangHai Caerulum Pharma Discovery Co., Ltd.	18149758185	sales-cpd@caerulumpharma.com	China	3420	58
Sichuan Wei Keqi Biological Technology Co., Ltd.	028-81700200 18116577057	3003855609@qq.com	China	7892	56
Sigma-Aldrich	021-61415566 800-8193336	orderCN@merckgroup.com	China	51471	80

Supplier	Advantage
ATK CHEMICAL COMPANY LIMITED	60
TargetMol Chemicals Inc.	58
Chemia Biotechnology（Shanghai） Co., Ltd	58
InvivoChem	58
Nantong HI-FUTURE Biology Co., Ltd.	58
Jilin Chinese Academy of Sciences-yanshen Technology	58
Aladdin Scientific	58
ShangHai Caerulum Pharma Discovery Co., Ltd.	58
Sichuan Wei Keqi Biological Technology Co., Ltd.	56
Sigma-Aldrich	80

1221277-90-2(GSK 2033)Related Search:

GSK2837808A GSK6853 GSK-A1 S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide GSK864

GSK484 GSK J4 HCl GSK 2334470 GSK2982772 GSK2636771

Benzeneacetamide, α-[[6-(4-amino-1-piperidinyl)-3,5-dicyano-4-ethyl-2-pyridinyl]thio]- GSK778 N-(6-Fluoro-1H-indazol-5-yl)-2-methyl-6-oxo-4-[4-(trifluoromethyl)phenyl]-1,4,5,6-tetrahydro-3-pyridinecarboxamide 2-((4-(benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl dihydrogen phosphate N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide

GSK-2256098 GSK215

1of4

GSK 2033 LXR antagonist 2033 2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide Benzenesulfonamide, 2,4,6-trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]- GSK2033 >=98% (HPLC) Liver X receptor,Inhibitor,GSK 2033,inhibit,LXR,GSK2033,GSK-2033 1221277-90-2 C29H28F3NO5S2